• linkedin
  • Increase Font
  • Sharebar

    The 5 Latest FDA Drug Approvals

    The FDA has already approved 24 new drugs in 2017.



    RADICAVA (edaravone injection), MT Pharma America

    Indications: Treatment of amyotrophic lateral sclerosis (ALS)

    Dosage: 60 mg administered as an intravenous infusion over 60 minutes; Initial treatment cycle: daily dosing for 14 days followed by a 14-day drug-free period; Subsequent treatment cycles: daily dosing for 10 days out of 14- day periods, followed by 14-day drug-free periods.

    Contraindications: Patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in RADICAVA.

    Read the full label here

    Previous ButtonNext Button


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available